Fetal–maternal microchimerism: impact on hematopoietic stem cell transplantation
✍ Scribed by Tatsuo Ichinohe; Takanori Teshima; Ken-ichi Matsuoka; Etsuko Maruya; Hiroh Saji
- Publisher
- Elsevier Science
- Year
- 2005
- Tongue
- English
- Weight
- 139 KB
- Volume
- 17
- Category
- Article
- ISSN
- 0952-7915
No coin nor oath required. For personal study only.
✦ Synopsis
Reciprocal cell traffic between mother and fetus during pregnancy gives rise to postpartum fetal-maternal lymphohematopoietic microchimerism, which is frequently detected in blood or tissue from healthy individuals. Although such microchimerism has been implicated in the pathogenesis of autoimmune diseases and tissue repair, recent clinical experiences have suggested the association of microchimerism with acquired immunologic hyporesponsiveness to non-inherited maternal HLA antigens (NIMAs) or inherited paternal HLA antigens (IPAs); T cell-replete HLA-haploidentical hematopoietic stem cell transplantation from a microchimeric IPA/NIMA-mismatched donor confers relatively lower incidence of severe graft-versus-host disease. The underlying mechanisms by which fetal-maternal microchimerism contributes to IPA/NIMA-specific tolerance are still elusive, although emerging experimental evidence suggests an involvement of the central deletion of IPA/NIMA-reactive T cells, the induction of peripheral regulatory T cells, and affinity-dependent modulation of NIMA-reactive B cells.
📜 SIMILAR VOLUMES
Peripheral blood stem cells (PBSC) reinfusion appears to hasten hematologic reconstitution following myeloablative therapy. While procurement of PBSC adds apheresis procedures, rapid engraftment could decrease the demand for platelet transfusions. To determine the impact of PBSC collection on worklo
VTE), including both deep venous thrombosis (DVT) and pulmonary embolism (PE), is an important cause of morbidity and mortality in children. Although there is heightened awareness of this disease and its risk factors in children, there has been minimal evaluation of diagnostic tests (clinical predic
We retrospectively evaluated the effect of the blood cyclosporine (CsA) concentration on the outcome of allogeneic hematopoietic stem cell transplantation from an HLA-matched sibling donor in 171 patients who received a continuous infusion of CsA and short-course methotrexate to prevent graft-versus